← Oncology Approval Tracker

FDA DECISION ·

Apalutamide (Erleada reference)

apalutamide · Zydus Worldwide DMCC

First generic approvalFirst genericProstate cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic apalutamide tablets for metastatic castration-sensitive or nonmetastatic castration-resistant prostate cancer.

LAMPGEN ANALYSIS

Why it matters

The first generic creates another sourcing option for androgen receptor blockade in two distinct prostate cancer settings.

What research teams should watch

Continue tracking castration status, oral refill continuity, and drug interactions during any formulary transition.

PRIMARY RECORDS

Sources